BHCM
ESPR icon

Brevan Howard Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Brevan Howard Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$126K Sell
46,138
-122,892
-73% -$389K ﹤0.01% 1986
2025
Q4 		$625K Sell
169,030
-94,246
-36% -$305K 0.01% 989
2025
Q3 		$698K Buy
263,276
+184,561
+234% +$357K 0.01% 1104
2025
Q2 		$77.1K Buy
78,715
+45,782
+139% +$45.8K ﹤0.01% 1797
2025
Q1 		$47.4K Buy
+32,933
New +$60.7K ﹤0.01% 1091
2024
Q2 		– Sell
-69,025
Closed -$185K – 1151
2024
Q1 		$185K Buy
+69,025
New +$168K 0.02% 815

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return